Taysha Gene Therapies (TSHA) Selling, General & Administrative (2020 - 2026)
Taysha Gene Therapies (TSHA) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Taysha Gene Therapies | 2.07 Bn | 2.07 Bn | - | 9.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.68 Mn |
| Dec 31, 2025 | 8.83 Mn |
| Sep 30, 2025 | 8.28 Mn |
| Jun 30, 2025 | 8.60 Mn |
| Mar 31, 2025 | 8.16 Mn |
| Dec 31, 2024 | 6.63 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.34 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Dec 31, 2023 | -20.73 Mn |
| Sep 30, 2023 | 8.59 Mn |
| Jun 30, 2023 | 5.99 Mn |
| Mar 31, 2023 | 8.75 Mn |
| Dec 31, 2022 | 7.34 Mn |
| Sep 30, 2022 | 8.68 Mn |
| Jun 30, 2022 | 9.87 Mn |
| Mar 31, 2022 | 11.47 Mn |
| Dec 31, 2021 | 11.81 Mn |
| Sep 30, 2021 | 11.15 Mn |
| Jun 30, 2021 | 10.13 Mn |